Labiotech.eu

Expert Advice 14 Dec 2020

How to Hire and Retain Talent in the Biotech Industry

Hiring is a big challenge for biotech companies; life sciences recruitment experts share their strategies for attracting and retaining talent in the biotech industry. The big obstacle for life sciences recruiters is that companies in this industry generally require highly qualified candidates with very specific skills. “As every company is very specialized in what they […]

December 14, 2020 - 7 minutesmins - By Clara Rodríguez Fernández

Covid 19 manufacturing vaccine therapies antibody

News and Trends 9 Dec 2020

The Manufacturing Challenge to Meet Covid-19 Vaccine Demands

Companies developing vaccines, drugs, and diagnostics for Covid-19 are being forced to scale up manufacturing at high speed in order to meet the enormous demand. There has been an unprecedented amount of research carried out over the last year to develop vaccines, drugs, and diagnostic tests to combat the Covid-19 pandemic. Before Canada gave the […]

December 9, 2020 - 5 minutesmins - By Helen Albert

tourette syndrome treatment noema pharma

News and Trends 7 Dec 2020

Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures

In spite of recent failures of clinical trials from others in the field, Swiss company Noema Pharma is gearing up to develop better treatments for the neurological condition Tourette’s syndrome. Noema Pharma will use a recent €49M Series A round to bankroll the phase I development of a candidate for Tourette’s syndrome along with the […]

December 7, 2020 - 3 minutesmins - By Jonathan Smith

In Depth 7 Dec 2020

Are We Still Friends? What Brexit Means for UK Synthetic Biology

Synthetic biology is one of the big strengths of UK science, but can the country uphold its vantage point after Brexit, without the support of the EU? (Disclaimer: At the time of writing, no deal has been made between the UK and the EU following Brexit. This intrepid writer is an Irish citizen who made […]

December 7, 2020 - 8 minutesmins - By David Kirk

News and Trends 4 Dec 2020

EU Launches Pharma Strategy, Raising Both Hopes and Questions

The public’s response has been cautious after the European Union unveiled a pharmaceutical strategy last week designed to spur domestic innovation and the production of affordable, state-of-the-art therapies. Amid a boom in biotech funding driven by the Covid-19 pandemic, the European Commission (EC) is scrambling to bring its sometimes fragmented pharma regulatory framework up to […]

December 4, 2020 - 6 minutesmins - By Victor Kotsev

In Depth 30 Nov 2020

Can Anti-Aging Research Keep Us Healthy in the Long Run?

Searching for the fountain of eternal youth has been the dream of humanity for millennia. While this is still in the realm of science fiction, anti-aging companies are hoping to tackle age-related diseases by targeting the underlying biology of aging. While we’ve been hunting for immortality for millennia, there hasn’t been much success. However, an […]

November 30, 2020 - 10 minutesmins - By Jonathan Smith

gene therapy blood disorder hemophilia b

News and Trends 27 Nov 2020

uniQure Stocks Up With First Phase III Results of Hemophilia B Gene Therapy

Gene therapies for the rare blood clotting disorder hemophilia B have taken a step closer to the market as Dutch developer uniQure became the first to release interim phase III results last week. Hemophilia is an inherited disease caused by mutations to genes encoding blood clotting proteins, resulting in uncontrollable bleeds. In severe cases of […]

November 27, 2020 - 5 minutesmins - By Victor Kotsev

News and Trends 26 Nov 2020

AstraZeneca’s Covid-19 Vaccine Proves Its Worth in Phase III

A much anticipated Covid-19 vaccine, developed by the University of Oxford and AstraZeneca, achieved 70% efficacy in phase III interim data. While less effective on paper, it could prove cheaper and easier to distribute than its most advanced competitors. Scientists and politicians heartily received the announcement of promising interim clinical trial results from the Covid-19 […]

November 26, 2020 - 4 minutesmins - By Kostas Vavitsas

Expert Advice 25 Nov 2020

How to Weather Bad Press as a Biotech Company

Biomedical companies face unique challenges when it comes to media communication. Crisis communication, in particular, can make or break a company — all the more so in a sector as sensitive as healthcare. Crises can strike a biotech company at any point — the dream partner company that had shot you to fame dumps you […]

November 25, 2020 - 7 minutesmins - By Victor Kotsev

cancer treatments immuno oncology companies

News and Trends 23 Nov 2020

SynOx Joins Wave of Biotechs Attacking Solid Tumor ‘Comfort Zone’

The newly founded SynOx has become the latest startup to attack solid tumors via their ‘comfort zone’, known as the tumor microenvironment. SynOx was spun out of the UK firm Celleron Therapeutics last week with a huge Series A round of €37M. The fledgling company is developing an antibody drug that Celleron licensed from Roche […]

November 23, 2020 - 4 minutesmins - By Jonathan Smith

Interview 23 Nov 2020

CDMOs Are the Unsung Heroes of the Gene and Cell Therapy Revolution

Cell and gene therapy is booming amid the ongoing pandemic, and this is driving up demand for synthetic DNA products, often produced and delivered by CDMOs. Karen Fallen started her career at Celltech Biologics in the UK, which was acquired in 1996 by Swiss giant Lonza, a world leader in the pharmaceutical manufacturing space. She […]

November 23, 2020 - 5 minutesmins - By Helen Albert

News and Trends 20 Nov 2020

Breakthroughs in Decentralized Testing Could Contain Covid-19

Hospital facilities in Europe are being pushed to their limits as the Covid-19 pandemic continues into winter. Coronavirus testing that doesn’t require a central lab is now arriving on the scene, and it could be the solution to effectively monitor and contain the disease. Despite the recent announcements of promising phase III data on Covid-19 […]

November 20, 2020 - 4 minutesmins - By Kostas Vavitsas

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

How to Hire and Retain Talent in the Biotech Industry

The Manufacturing Challenge to Meet Covid-19 Vaccine Demands

Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures

Are We Still Friends? What Brexit Means for UK Synthetic Biology

EU Launches Pharma Strategy, Raising Both Hopes and Questions

Can Anti-Aging Research Keep Us Healthy in the Long Run?

uniQure Stocks Up With First Phase III Results of Hemophilia B Gene Therapy

AstraZeneca’s Covid-19 Vaccine Proves Its Worth in Phase III

How to Weather Bad Press as a Biotech Company

SynOx Joins Wave of Biotechs Attacking Solid Tumor ‘Comfort Zone’

CDMOs Are the Unsung Heroes of the Gene and Cell Therapy Revolution

Breakthroughs in Decentralized Testing Could Contain Covid-19

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!